Related Experiment Video
Updated: Jul 10, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.4K
Incorporating variable RBE in IMPT optimization for ependymoma.
Hadis Moazami Goudarzi1, Gino Lim1, David Grosshans2
1Department of Industrial Engineering, University of Houston, Houston, Texas, USA.
Journal of Applied Clinical Medical Physics
|November 21, 2023
Summary
Incorporating variable relative biological effectiveness (RBE) in intensity-modulated proton therapy (IMPT) optimization shows promise. A hybrid RBE approach maintained dose limits while reducing high RBE in critical tissues for pediatric ependymoma patients.
Area of Science:
- Medical Physics
- Radiation Oncology
- Biophysics
Background:
- Intensity-modulated proton therapy (IMPT) is an advanced radiation technique.
- Relative biological effectiveness (RBE) of protons can vary depending on factors like linear energy transfer (LET).
- Accurate RBE modeling is crucial for optimizing proton therapy plans.
Purpose of the Study:
- To assess the dosimetric impact of variable proton RBE in IMPT.
- To compare variable RBE optimization with constant RBE and LET-based methods.
- To evaluate optimization strategies for pediatric ependymoma treatment.
Main Methods:
- Four optimization strategies were compared in 10 pediatric ependymoma patients: constant RBE, LET-based, variable RBE, and hybrid RBE.
- Plans were normalized for target coverage.
- Dose, dose-averaged LET (LETd), LET-weighted dose, and equivalent uniform dose were analyzed.
Main Results:
- LET-based optimization increased LET in targets and maintained or decreased it in critical organs.
- Variable RBE optimization reduced mean and maximum doses in the brainstem and spinal cord.
- Hybrid RBE optimization achieved higher target doses and reduced high RBE in critical tissues compared to other methods.
Conclusions:
- Direct incorporation of variable RBE models into IMPT optimization is feasible.
- A hybrid RBE optimization strategy shows clinical potential for ependymoma treatment.
- This approach can maintain dose limits while minimizing high RBE in normal tissues.

